Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience (Front. Oncol., (2022), 12, 883399, 10.3389/fonc.2022.883399)

In the published article, there was an error in affiliations 3 and 4. Instead of “3. Division of Clinical Research, Department of Medical Research and Division of Medical Oncology, Center for Immuno-oncology, Taipei, Taiwan, 4 Department of Oncology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan”, it should be “3. Division of Clinical Research, Department of Medical Research and Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, 4. National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan”. In the published article, an author name was incorrectly written as “Sean M.N. Wong”. The correct spelling is “Natalie S.M. Wong”. In the published article, there was an error in the Funding statement. An acknowledgement was missed. The correct Funding statement appears below. Funding This work was supported in part by the Chang Gung Memorial Hospital CMRPG3J0971~3 CORPG3J0251~3. We thank to Zai Lab (Taiwan) Limited for the educational grant to Taiwan Society of Molecular Medicine. The funder Zai Lab (Taiwan) was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.